Cargando…
Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication
Hepatitis C virus is major cause of chronic liver diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Presently available direct-acting antiviral drugs have improved success rate; however, high cost limits their utilization, especially in developing countries like Indi...
Autores principales: | Mandal, Anirban, Ganta, Krishna Kumar, Chaubey, Binay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942654/ https://www.ncbi.nlm.nih.gov/pubmed/27446609 http://dx.doi.org/10.1155/2016/9671031 |
Ejemplares similares
-
Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009) -
GPS2 Is Required for the Association of NS5A with VAP-A and Hepatitis C Virus Replication
por: Xu, Guodong, et al.
Publicado: (2013) -
HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011) -
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011) -
Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replication
por: Tsai, Kevin, et al.
Publicado: (2018)